The association of IDO activity with markers of type 1 immunity and markers of systemic inflammation and immune activation in healthy subjects of this study is consistent with the idea that the expression of IDO and production of Kyn, as well as these markers of systemic inflammation and immune activation, are all driven by a common underlying factor, such as obesity. This evidence concerns the gene IDO1 and obesity disorder.